grant

Structural and Functional Alteration of host RBCs by Babesia

Organization NEW YORK BLOOD CENTERLocation NEW YORK, UNITED STATESPosted 13 Dec 2024Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY2025AffectAnimalsAnkyrinsAntibodiesAspartic EndopeptidasesAspartic ProteinasesAspartyl ProteasesAspartyl ProteinasesAssayB microtiB. microtiBabesiaBabesia infectionBabesia parasite infectionBabesiosisBioassayBiochemicalBiological AssayBloodBlood Reticuloendothelial SystemBlood erythrocyteBorrelia microtiCarboxyl (Acid) ProteinasesCarboxylic ProteinasesCaspaseCaspase GeneCausalityCell BodyCell Surface AntigensCell membraneCell-Death ProteaseCellsCellular MatrixCellular MorphologyCellular biologyClinicalCysteine EndopeptidasesCysteine ProteaseCysteine ProteinasesCytoplasmCytoplasmic MembraneCytoskeletal GeneCytoskeletal ProteinsCytoskeletal SystemCytoskeletonDataDiseaseDisease OutcomeDisorderDomestic AnimalsDysfunctionElementsEnsureErythrocytesErythrocyticEsteroproteasesEtiologyFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryFunctional disorderFundingGenerationsGeographyGoalsGrantHLA-DR Associated Protein IIHumanICE-like proteaseIGAADImageImmune PrecipitationImmunocompromisedImmunocompromised HostImmunocompromised PatientImmunological Surface MarkersImmunoprecipitationImmunosuppressed HostIndividualInfectionInhibitor of GZMA-Activated DNaseInstitutionInvadedIxodesIxodes tickLife CycleLife Cycle StagesLinkMachine LearningMapsMarrow erythrocyteMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMediatingMediatorMembraneMentorsMentorshipMethodsMicroscopyMissionModelingModern ManModificationMolecularMorphologyNIAIDNational Institute of Allergy and Infectious DiseaseNatureNew YorkOsmotic FragilityOsmotic Fragility testParasitesParasitologyPathologicPatternPeptidasesPeptide HydrolasesPhosphatase 2A Inhibitor I2PP2APhosphorylationPhysiologicPhysiologicalPhysiopathologyPiroplasmaPiroplasmosisPlasma MembranePopulationPrevalencePreventionProliferatingPropertyProtease GeneProteasesProtein ExportProtein Export PathwayProtein PhosphorylationProteinasesProteinsProteolytic EnzymesProteomicsPublic HealthRed Blood CellsRed CellResearchResistanceSET Translocation Inhibitor-2 of Protein Phosphatase-2ASet proteinSpectrinSurface AntigensSurface Plasmon ResonanceSymptomsTechniquesTemplate Activating Factor I BetaTherapeuticTrainingTransmissionTreatment ProtocolsTreatment RegimenTreatment ScheduleVariantVariationVesicleZoonosesZoonoticZoonotic Infectionaspartate proteaseaspartic proteasebiophysical analysisbiophysical characteristicsbiophysical characterizationbiophysical measurementbiophysical parametersbiophysical propertiesbiophysical studiesblood corpusclescareercareer developmentcausationcell biologycell morphologycystein proteasecystein proteinasecysteine endopeptidasedesigndesigningdisease causationdomesticated animalexperienceflow cytophotometryhospitalization ratesimagingimmunosuppressed patientinfected with Babesiainsightintracellular skeletonlife coursemachine based learningmembrane skeletonmembrane structurenovelosmotic fragility blood testparasite invasionpathogenpathophysiologyplasmalemmaresistantside effectskillstick-bornetick-borne pathogentickbornetickborne pathogentooltransmission process
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Babesia spp., the etiologic agents of babesiosis in animals and humans, are intraerythrocytic protozoan parasites
transmitted to hosts by Ixodes ticks. Long known to cause disease in domestic animals, B. microti and B.

divergens have emerged as a growing public health concern for humans, causing fulminant disease in immuno-

compromised and asplenic populations and an alarmingly high rate of hospitalizations and sometimes fatality in

these individuals. Most clinical complications are due to the ability of the parasites to strikingly alter properties of

host RBCs. I hypothesize that structural, morphological, rheological, and functional changes occurring

in infected RBCs (iRBCs) are the result of the export of specific Babesia proteins, including proteases,

which interact with the cytoplasmic, membrane skeletal and membrane components of the RBCs. The

overarching goal of this proposal is to elucidate the alterations to the host RBCs and uncover the mechanisms

underlying these changes by identifying and characterizing the molecular players-both impacted RBC

cytoskeletal proteins and the key parasite molecules responsible for the changes, to build a comprehensive

picture of host RBC remodeling during infection. Aim 1 will conduct morphological, rheological, and biophysical

analyses to define alterations of iRBCs using Image flow cytometry along with machine learning analysis,

ektacytometry and Stimulated Emission Depletion microscopy. Changes in 5 key RBC cytoskeletal proteins on

infection-Band 3, spectrin, ankyrin, Proteins 4.1 and 4.2, will be mapped. Specific antibodies will be used in

immuno-chemical methods to track changes in these cytoskeletal elements up on infection and mass

spectrometry performed to identify specific phosphorylation and cleavage modifications. Aim 2 will identify and

characterize 2 parasite cysteine proteases and 2 aspartic proteases including their processing, sub-cellular

localization, identification of export sequence signatures and develop molecular tools for downstream functional

analysis. The specific interactions of these proteases with the host RBC cytoskeleton proteins will be studied

using inside-out RBC vesicle assays, immunoprecipitation, and Surface Plasmon Resonance to identify specific

interactions and delineate the domains required for modification of host cytoskeletal proteins. Overall, these aims

will provide insights into mechanisms of RBC remodeling by the parasite and its physiological relevance in

babesiosis, opening doors for novel and targeted chemotherapeutics, in line with NIAID’s mission to tackle

emerging diseases relevant to public health. A comprehensive mentorship team (Drs. Lobo, Narla, Hillyer,

Yazdanbakhsh, Montero, Allred, Monetti and North) has been assembled to ensure that both scientific and career

development goals are met. The immediate goal is to gain advanced training in a relatively understudied parasite

using multipronged experimental approaches, along with acquiring soft skills needed for scientific independence.

This K99/R00 grant would eventually provide data and molecular tools for R01-level funding, fulfilling long-term

career goals for launching an independent career in studying host-parasite interaction in babesiosis.

Grant Number: 1K99AI182422-01A1
NIH Institute/Center: NIH

Principal Investigator: Divya Beri

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →